{"id":39850,"date":"2018-06-06T10:04:48","date_gmt":"2018-06-06T14:04:48","guid":{"rendered":"http:\/\/blogs.sld.cu\/marionod\/?p=39850"},"modified":"2018-06-06T10:04:48","modified_gmt":"2018-06-06T14:04:48","slug":"society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/marionod\/2018\/06\/06\/society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines\/","title":{"rendered":"Society for Immunotherapy of Cancer (SITC). Cancer Immunotherapy Guidelines"},"content":{"rendered":"<p><a href=\"http:\/\/www.sitcancer.org\/research\/cancer-immunotherapy-guidelines\" target=\"_blank\">Society for Immunotherapy of Cancer (SITC). Cancer Immunotherapy Guidelines <\/a><\/p>\n<p><span id=\"result_box\" class=\"\" lang=\"es\"><span class=\"\">La <a href=\"http:\/\/www.sitcancer.org\/\" target=\"_blank\">Sociedad para la Inmunoterapia del C\u00e1ncer<\/a> ha publicado una colecci\u00f3n de declaraciones de consenso desarrolladas por expertos para ayudar a los onc\u00f3logos a determinar cu\u00e1ndo y c\u00f3mo usar mejor la inmunoterapia para tratar a sus pacientes.<\/span> Las gu\u00edas se desarrollan utilizando un proceso sistem\u00e1tico para garantizar que las recomendaciones sean imparciales, relevantes y faciliten la toma de decisiones cl\u00ednicas. Las gu\u00edas ser\u00e1n evaluadas y actualizadas de forma continua.<br \/>\nEstas gu\u00edas de inmunoterapia contra el c\u00e1ncer espec\u00edficas de la enfermedad ofrecen un recurso vital para la comunidad oncol\u00f3gica en ejercicio.<\/span><\/p>\n<p>Estas gu\u00edas de pr\u00e1ctica cl\u00ednica y declaraciones de consenso tambi\u00e9n pueden accederse a trav\u00e9s de art\u00edculos publicados en la revista <a href=\"https:\/\/jitc.biomedcentral.com\/articles\/sections\/guidelines-and-consensus-statements\" target=\"_blank\">Journal for ImmunoTherapy of Cancer. <\/a>Idioma: ingl\u00e9s<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Society for Immunotherapy of Cancer (SITC). Cancer Immunotherapy Guidelines La Sociedad para la Inmunoterapia del C\u00e1ncer ha publicado una colecci\u00f3n de declaraciones de consenso desarrolladas por expertos para ayudar a los onc\u00f3logos a determinar cu\u00e1ndo y c\u00f3mo usar mejor la inmunoterapia para tratar a sus pacientes. Las gu\u00edas se desarrollan utilizando un proceso sistem\u00e1tico para [&hellip;]<\/p>\n","protected":false},"author":126,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[66,152,1757,19,485,22],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/39850"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/users\/126"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/comments?post=39850"}],"version-history":[{"count":1,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/39850\/revisions"}],"predecessor-version":[{"id":39851,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/posts\/39850\/revisions\/39851"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/media?parent=39850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/categories?post=39850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/marionod\/wp-json\/wp\/v2\/tags?post=39850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}